Recherche - Archive ouverte HAL

Notice
18
Document
2

Sciences du Vivant [q-bio]
20

2021
1
2017
1
2014
2
2012
1
2010
2
2009
4
2008
9

anglais
18
français
2

		Neonatal Fc receptor, key control of immunoglobulins biodistribution Charlotte Magdelaine-Beuzelin , Marc Ohresser , Herve Watier Médecine/Sciences, 2009, 25 (12), pp.1053-1056 Article dans une revue hal-00616365v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		G1m allotypes and development of antibodies-to-infliximab. Charlotte Magdelaine-Beuzelin , S. Vermeire , M. Goodall , Filip Baert , Marc Ohresser , et al. Immunogenicity for Biologics 2008, IBC Congress, Bâle (Suisse), 5-6 février., Feb 2008, BALE, Switzerland Communication dans un congrès hal-00320462v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		FcgRIIIa Expression Is Not Increased on Natural Killer Cells Expressing the FcgRIIIa-158V Allotype. Nicolas Congy-Jolivet , Armelle Bolzec , David Ternant , Marc Ohresser , Hervé Watier , et al. Cancer Research, 2008, 68, pp.976-980 Article dans une revue hal-00317889v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Tumor burden influences exposure and response to rituximab : pharmacokinetic - pharmacodynamic modelling using a syngeneic bioluminescent murine model expressing human CD20 David Dayde , David Ternant , Marc Ohresser , S. Lerondel , S. Pesnel , et al. Blood, 2009, 113, pp.3765-3772 Article dans une revue hal-00422647v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Evidence for Linkage Disequilibrium Between Fc gamma RIIIa-V158F and Fc gamma RIIa-H131R Polymorphisms in White Patients, and for an Fc gamma RIIIa-Restricted Influence on the Response to Therapeutic Antibodies Julien Lejeune , Gilles Thibault , David Ternant , Guillaume Cartron , Herve Watier , et al. Journal of Clinical Oncology, 2008, 26 (33), pp.5489-5491 Article dans une revue hal-00616492v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment. Guillaume Cartron , Marc Ohresser , G. Salles , P. Solal-Celigny , P. Colombat , et al. Annals of Oncology, 2008, 19, pp.1485-1487 Article dans une revue hal-00317865v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma Franck Bruyere , Christopher M. Hovens , Marie-Noelle Marson , Benjamin Faivre d'Arcier , Anthony J. Costello , et al. Journal of Urology, 2010, 184 (4), pp.1273-1278 Article dans une revue hal-00616339v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Feg receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the react study Corinne Miceli-Richard , Marc Ohresser , Philippe Goupille , Celine Verstuyft , Laura Contreras , et al. Arthritis and Rheumatism, 2008, 58 (9), pp.S900-S901 Article dans une revue hal-00618961v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Implications of receptors for the Fc portion of IgG (Fc gamma Rs) in mechanism of action of therapeutic antibodies Julien Lejeune , Gilles Thibault , Guillaume Cartron , Marc Ohresser , Herve Watier Bulletin du Cancer, 2010, 97 (5), pp.511-522. ⟨10.1684/bdc.2010.1077⟩ Article dans une revue hal-00616358v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		FcgRIIIa expression is not increased on natural killer cells expressing the FcgRIIIa-158V allotype. Nicolas Congy-Jolivet , A. Bolzec , David Ternant , Marc Ohresser , Hervé Watier , et al. 3èmes Journées du Cancéropôle Grand Ouest, Nantes, 10-11 mars., Mar 2008, NANTES, France Communication dans un congrès hal-00320385v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgRIIIa genetic polymorphism. David Ternant , M. Buchler , M. Beneton , G. Alvan , Marc Ohresser , et al. British Journal of Clinical Pharmacology, 2008, 65, pp.60-68 Article dans une revue hal-00318128v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Fcγ receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the ReACT study. Corinne Miceli-Richard , Marc Ohresser , Philippe Goupille , Céline Verstuyft , L. Contreras , et al. Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.325 (SAT0131) Communication dans un congrès hal-00320148v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab Charlotte Magdelaine-Beuzelin , Severine Vermeire , Margaret Goodall , Filip Baert , Maja Noman , et al. Pharmacogenet. Genomics, 2009, 19 (5), pp.383-387 Article dans une revue hal-00616452v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies Christophe Passot , Nicolas Azzopardi , Sylvaine Renault , Nadine Baroukh , Christophe Arnoult , et al. mAbs, 2014, 5 (4), pp.614 - 619. ⟨10.4161/mabs.24815⟩ Article dans une revue hal-01769897v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20 David Dayde , David Ternant , Marc Ohresser , Stephanie Lerondel , Sabrina Pesnel , et al. Blood, 2009, 113 (16), pp.3765-3772 Article dans une revue hal-00616466v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Evidence for linkage disequilibrium between FcyRIIIa-V158F and FcyRIIa-H131R polymorphisms in Caucasians, and for an FcyRIIIa-restricted influence on the response to therapeutic antibodies. Julien Lejeune , Gilles Thibault , David Ternant , Guillaume Cartron , Hervé Watier , et al. Journal of Clinical Oncology, 2008, 26 (26), pp.1789-96 Article dans une revue hal-00422495v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population Julien Lejeune , Benoit Piegu , Valérie Gouilleux-Gruart , Marc Ohresser , Hervé Watier , et al. mAbs, 2012, 4 (6), pp.784-787. ⟨10.4161/mabs.22287⟩ Article dans une revue hal-01129675v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations Celine Desvignes , David Ternant , Thierry Lecomte , Astrid Lièvre , Marc Ohresser , et al. Bioanalysis, 2021, 13 (7), pp.565-574. ⟨10.4155/bio-2020-0199⟩ Article dans une revue inserm-03186974v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer? Sajida Ibrahim , Alban Girault , Marc Ohresser , Emilie Lereclus , Gilles Paintaud , et al. Clinical Colorectal Cancer, 2017, ⟨10.1016/j.clcc.2017.10.003⟩ Article dans une revue inserm-01661759v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population Julien Lejeune , Benoit Piegu , Valérie Gouilleux-Gruart , Marc Ohresser , Herve Watier , et al. mAbs, 2014, 4 (6), pp.784-787. ⟨10.4161/mabs.22287⟩ Article dans une revue hal-02425422v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More

Filtrer vos résultats

Neonatal Fc receptor, key control of immunoglobulins biodistribution

G1m allotypes and development of antibodies-to-infliximab.

FcgRIIIa Expression Is Not Increased on Natural Killer Cells Expressing the FcgRIIIa-158V Allotype.

Tumor burden influences exposure and response to rituximab : pharmacokinetic - pharmacodynamic modelling using a syngeneic bioluminescent murine model expressing human CD20

Evidence for Linkage Disequilibrium Between Fc gamma RIIIa-V158F and Fc gamma RIIa-H131R Polymorphisms in White Patients, and for an Fc gamma RIIIa-Restricted Influence on the Response to Therapeutic Antibodies

Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.

VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma

Feg receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the react study

Implications of receptors for the Fc portion of IgG (Fc gamma Rs) in mechanism of action of therapeutic antibodies

FcgRIIIa expression is not increased on natural killer cells expressing the FcgRIIIa-158V allotype.

Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgRIIIa genetic polymorphism.

Fcγ receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the ReACT study.

IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20

Evidence for linkage disequilibrium between FcyRIIIa-V158F and FcyRIIa-H131R polymorphisms in Caucasians, and for an FcyRIIIa-restricted influence on the response to therapeutic antibodies.

FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population

A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population